NCT04020510View on ClinicalTrials.gov

Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder

PHASE4RecruitingINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

July 1, 2021

Study Completion Date

December 31, 2021

Conditions
Overactive Bladder
Interventions
DRUG

onaBoNT-A

Intradetrusor onabotulinumtoxinA in either the standard number of injections or a reduced number of injections

Trial Locations (1)

20889

RECRUITING

Walter Reed National Military Medical Center, Bethesda

All Listed Sponsors
lead

Walter Reed National Military Medical Center

FED